The aim of this work was the preparation, characterization and preliminary evaluation of the targeting ability towards pancreatic adenocarcinoma cells of liposomes containing the gemcitabine lipophilic prodrug [4-(N)-lauroyl-gemcitabine, C12GEM]. Hyaluronic acid (HA) was selected as targeting agent since it is biodegradable, biocompatible, can be chemically modified and its cell surface receptor CD44 is overexpressed on various tumors.
1.Introduction
Gemcitabine (2',2'-difluoro-2'-deoxycytidine, GEM) is an anticancer nucleoside analogue of deoxycytidine that is active against solid tumors, including colon, lung, pancreatic, breast, bladder and ovarian cancers [1] [2] [3] . In particular, GEM was approved by the Food and Drug Administration in May 1996 for use against advanced or metastatic pancreatic cancer [4] .
GEM is itself a prodrug since, once inside the cell, it is metabolically-activated through phosphorylation at 5' by deoxycytidine kinase, which gives the monophosphate derivative. The drug is further phosphorylated to the di-and then to the triphosphate analogue, which is incorporated into the DNA chain during replication, inhibiting DNA synthesis and cell growth [5, 6] .
However, GEM is also rapidly deaminated by deoxycytidine deaminase, which locates essentially in the blood, liver and kidneys, and rapidly degrades GEM to the chemotherapeutically-inactive uracil derivative [7] [8] [9] . Thus, when administered intravenously, GEM has a very short plasma halflife, which is a major limitation of this anticancer compound [10] [11] [12] .
In the clinical practice, this limitation has been overcome through a therapeutic schedule with repeated administration regimes in order to achieve therapeutic drug levels.
Recent works have been focused on an alternative approach to increase the effectiveness of the therapy by encapsulating GEM into liposomes. The results in terms of cytotoxic activity were very promising in different in vitro and in vivo studies [13] [14] [15] [16] [17] . In our previous work, in order to obtain both a physical and a chemical protection of the drug, we have synthesized and incorporated into liposomes lipophilic GEM prodrugs that were obtained by linking the N 4 -amino group with linear acyl chains of different length which enhanced drug incorporation and antitumoral activity [18, 19] .
Active targeting to tumor tissue of drug-containing liposomes is useful to further increase their activity and specificity. The overexpression of the hyaluronic acid (HA) principal cell surface receptor, CD44, on a variety of tumors such as epithelial, ovarian, colon, stomach and acute leukemia [20] makes it a vector for targeting procedure against these tumors [21, 22] .
HA is a high-molecular-weight glycosaminoglycan polymer (MW = 10 6 Da) composed of repeating units of D-glucuronic acid and N-acetyl-D-glucosamine linked together through alternating β-1,3
and β-1,4 glycosidic bonds [23, 24] . HA has many physiological roles that include tissue and matrix water regulation, structural and space-filling properties, lubrication and a number of macromolecular functions [25] .
In the preparation of liposomes targeted to tumor cells, the choice of the HA in terms of size is a crucial aspect: both high molecular weight (HMW) HA [26] and oligomers of low molecular weight (LMW) [27] have been employed.
Here, we decided to use HA of two different LMW (4800 and 12000 Da) and to compare the targeting ability of liposomes decorated with the two kinds of polymer.
The present study describes the preparation, characterization and preliminary evaluation of the biological properties on highly CD44-expressing human pancreatic adenocarcinoma cell lines of liposomes coated with HA and encapsulating a lipophilic GEM prodrug.
To this purpose, molecular conjugates between the phospholipid 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine and HA were synthesized and incorporated in the liposomal preparations.
Material and methods

Materials and instruments
Sodium hyaluronate of MW 4800 (HA4800) and 12000 (HA12000) Da was purchased from Lifecore Biomedical (Chaska, MN). All the phospholipids were provided by Avanti Polar-Lipids distributed by Spectra 2000 (Rome, Italy). The cholesterol and all the other chemicals were obtained from Sigma-Aldrich (Milan, Italy). All the solvents used were of analytical grade, purchased from Carlo Erba Reagenti (Milan, Italy). The 1 H nuclear magnetic resonance (NMR) spectra were recorded on a Bruker 300 Ultrashield instrument (Karlsruhe, Germany) in a mixture of D2O, CD3OD, CF3CO2D in a volume ratio of 6:3:1 at room temperature, with Me4Si (TMS) as internal standard.
The reactions were monitored by thin-layer chromatography (TLC) on F245 silica gel pre-coated sheets (Merck, Milan, Italy). The 4-(N)-lauroyl-gemcitabine (C12GEM) was synthesized according to Immordino et al. [18] . Fluorescein-5-(and-6)-sulfonic acid trisodium salt and Lissamine™ rhodamine B 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine triethylammonium salt (rhodamine-DHPE) were provided by Invitrogen (Life Technologies, Monza, Italy).
Synthesis and characterization of hyaluronated conjugates
Hyaluronated conjugates were synthesized as described by Ruhela et al. [28] with minor modifications. Briefly, 0.060 mmol of HA (HA4800 0.3 g; HA12000 0.72 g) was quite completely dissolved in 20 ml of methanol and dimethyl sulfoxide (1:1 v/v) and stirred at 60 °C. After 30 min, 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE) (0.038 g, 0.060 mmol) previously dissolved in 2 ml of methanol and chloroform (1:1 v/v) was added to the HA solution. Then, acetic acid was added and the pH was adjusted at 4.5 and the mixture was stirred for 2 h at 60 °C.
Subsequently, sodium triacetoxyborohydride [NaBH(OAc)3] (0.038 g, 0.180 mmol) dissolved in 2 ml of methanol and chloroform (1:1 v/v) was added dropwise. The reaction proceeded for 96 h at 60 °C under magnetic stirring (Fig.1) .
The reactions were monitored by TLC using chloroform/methanol (65:30 v/v). After migration of the mobile phase, sheets were exposed to iodine vapors, solution of molybdenum blue and ninhydrin (2,2-dihydroxyindene-1,3-dione) solution (100 mg/100 ml ethanol).
After removal of the solvent under reduced pressure, the crude product was resuspended in a modest amount of water. Then, in order to remove LMW unreacted compounds, the product was purified by an overnight dialysis at 4 °C against distilled water using a Spectra/Por regenerated cellulose membrane (Spectrum, Breda, The Nederlands) with a molecular cutoff of 3,500 and then freeze-dried.
The final product was purified from unreacted DPPE and HA by automated chromatography on a 
Preparation of liposomes
Liposomes were prepared by thin lipid film hydration and extrusion method. Briefly, a chloroform solution of the lipid components 1,2-dipalmitoyl-phosphatidylcholine (DPPC), cholesterol (Chol) and L-α-phosphatidyl-DL-glycerol sodium salt (PG) (70:30:3 molar ratios) was evaporated and the resulting lipid film was dried under vacuum overnight.
To prepare liposomes containing C12GEM, methanol solution of the prodrug and chloroform solutions of lipids were mixed in 30% ratio (mol drug/mol lipid).
Lipid films were hydrated with a 20 mM 4-(2-hydroxyethyl)piperazine-1-ethanesulforic acid (HEPES) buffer (pH 7.4) and the suspension was vortex mixed for 10 min and bath sonicated.
The formulations were extruded (Extruder, Lipex, Vancouver, Canada) at 60° C passing the suspension 10 times under nitrogen through 100 nm polycarbonate membrane (Costar, Corning Incorporated, NY).
To prepare hyaluronated liposomes, the same method of preparation was used. Lipid films were made up of DPPC:Chol (70:30 molar ratios) and then hydrated using solution of the different HA-DPPE conjugates (3 molar ratio) in HEPES.
For the in vitro studies, fluorescent labeled liposomes were prepared as described above and a 10 mM solution of fluorescein-5-(and-6)-sulfonic acid trisodium salt in HEPES buffer was used during hydration.
Liposomal preparations were purified from unentrapped compounds [C12GEM or fluorescein-5-(and-6)-sulfonic acid trisodium salt] through chromatography on Sepharose CL-4B columns, eluting with HEPES buffer. Liposomes were stored at 4 °C.
Liposomes characterization
The mean particle size and polydispersity index of the liposomes were determined at 20 °C by Phospholipid phosphorous was assessed in each liposome preparation by phosphate assay after destruction with perchloric acid [29] .
The amount of C12GEM incorporated in liposomes was determined by HPLC (Merck Hitachi HPLC System, Milan, Italy). The liposomal suspension was diluted by adding water and acetonitrile (60:40) to a total volume of 0.5 ml. C12GEM was extracted by adding 4.0 ml of tertbutyl methyl ether and vortex-mixing the sample for 30 s. The mixture was then centrifuged for 15 min at 300 x g, after which 3 ml of the organic layer was transferred and evaporated to dryness under nitrogen stream. The residue was reconstituted with 100 µl of methanol, and 40 µl of the solution were injected into a Symmetry C18 column, 5µm (Merck, Milan, Italy) equipped with a C18 column guard (Merck, Milan, Italy). The column was eluted with methanol/water (90:10 v/v) flow rate 0.8 ml/min. Detection was by UV adsorption measurement at 248 nm. Peak heights were recorded and processed on a CBM-10A Shimadzu interface. The drug concentration was calculated from standard curves. The assay was linear over the tested concentration range (20-1000 ng).
Liposomal preparations were analyzed for physical stability in the storage conditions evaluating at different interval times diameter, zeta potential and drug leakage. Drug leakage was determined submitting 200 µl of liposomes to purification through chromatography on Sepharose CL-4B columns, eluting with HEPES buffer, and re-analyzing for drug and phospholipid content as described above. A change in content was interpreted as an indication of liposome instability.
The percentage of HA associated to the liposomes was determined by the carbazole assay [30] .
Differential Scanning Calorimetry (DSC)
DSC analysis was performed on hydrated samples using a differential scanning calorimeter (DSC 7, and n-decan (Tm=-29.6 ºC).
Transmission Electron Microscopy (TEM)
Sample preparations were performed as follows: 5 μl of each formulation were placed on 300 mesh coated copper grids (Lacey Formvar/Carbon, Ted Pella Inc., Redding, CA) allowed to adsorb and the excess amount of liquid was removed with a filter paper. Preparations were analyzed at room temperature on a Philips CM10 electron microscope operating at an accelerating voltage of 80 kV under low electron dose.
Cell culture
PaCa44, PaCa3, Panc1, CFPAC1, PT45P1, T3M4, Suit-2, MiaPaCa2, PC1J, HPAF II and PSN1
human pancreatic adenocarcinoma cell lines and VIT1 normal primary pancreatic mesenchymal cells were grown in RPMI 1640 supplemented with 10% FBS, 2 mM glutamine, 50 μg/ml gentamicin sulfate (Gibco, Life Technologies, Milan, Italy). Cells were incubated at 37 °C with 5% CO 2 . 
Receptor expression analysis
In vitro cytotoxicity assays
MiaPaCa2 and VIT1 cells were plated in 96-well cell culture plates (4 x 10 3 cells/well) and incubated overnight at 37 °C with 5% CO2. Then, cells were treated with the following samples:
GEM, C12GEM and liposomes: DPPC:Chol:PG + C12GEM (lipo C12), DPPC:Chol:HA4800-DPPE + C12 GEM (lipo C12 HA4800), and DPPC:Chol:HA12000-DPPE + C12 GEM (lipo C12 HA12000) and further incubated for 72 h. At the end of the treatments cell proliferation was evaluated by
Crystal Violet (Sigma-Aldrich, Milan, Italy) staining. Five independent experiments were performed for each assay condition. Cell viability was determined photometrically (A 595 nm).
Statistical analysis
ANOVA (post hoc Bonferroni) analysis was performed by GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA, USA). P values <0.05 were indicated as statistically significant.
Results and discussion
Synthesis of hyaluronated conjugates
In order to obtain liposomes containing HA and thus potentially able to bind CD44 receptor, conjugates between LMW HA and DPPE were synthesized. HA of two different MW (4800 and 12000 Da) were used with the aim to assess changes in the targeting effect as a function of polymer MW. The conjugates were prepared by reductive amination, a chemical reaction widely used in polysaccharide conjugation methods [31] , using NaBH(OAc)3 as reducing agent (Fig. 1 ). This borohydride reagent is an attractive alternative to the toxic but extensively used sodium cyanoborohydride, since it is mild and exhibits remarkable selectivity as a reducing agent [32] . The preparation of HA-DPPE conjugates consists in two steps. In the first step the aldehydic group, generated by the opening of the sugar ring, reacts in acidic medium with the amino group of DPPE forming the unstable imine. The imine formation is a very slow reaction that constitutes a limiting step of the global reductive amination. To accelerate the reaction that takes on the order of days to perform, it was carried out at 60 °C. Then the Schiff base or imine, which is formed initially in situ and is unstable, is reduced in presence of NaBH(OAc)3 to a secondary amine leading to the formation of the conjugate. The high reaction yield was obtained using a mixture of solvents as previously reported by Ruhela [28] : methanol and dimethylsulfoxyde for the HA, methanol and chloroform for the phospholipid and for NaBH(OAc)3.
Pure HA-DPPE conjugates were obtained using CombiFlash chromatography. This technique was very useful and fast and allowed to eliminate in a single step the unreacted HA and the phospholipid without loss of product. After purification and lyophilization, the conjugates were characterized by TLC: spots were ninhydrin negative and phosphate and iodine positive. Moreover, the 1 H NMR spectra of the conjugates showed the characteristic signals of both DPPE and HA moieties.
Preparation and characterization of liposomes
The HA4800-DPPE or HA12000-DPPE conjugates were added at a molar ratio of 3 during hydration to a lipid film composed of DPPC and Chol (70:30 molar ratio) containing 30 mol% of C12GEM.
For plain liposomes PG was used instead of HA-DPPE conjugates. The physicochemical characteristics of the different formulations are summarized in Table 1 . Liposomes displayed a dimensional range from about 150 nm to 190 nm and the particle size of the HA-liposomes tended to increase as the polymer MW increased. The polydispersity index was low for all the formulations (<0.15). Liposomes showed a negative Zeta potenzial value that was lower for hyaluronated liposomes compared to plain liposomes, due to the carboxylic negative residues of HA. In particular, the negative charge increased as the polymer MW increased. Those data were useful to confirm the presence of HA on the surface of the liposomes.
The efficiency of drug incorporation in fluid vesicles is strongly affected by drug polarity. Low molecular weight, water soluble molecules, such as GEM, diffuse rapidly through liposome bilayers. Our previous studies showed that the encapsulation efficiency was improved by using lipophilic GEM prodrugs [18] . Liposomes composed of DSPG:DSPC 9:1 containing the 20 mol% of C12GEM had an optimal entrapment efficiency of about 95% [18] . In the present study, similar results were obtained despite the more complex formulation consisting of actively targeted liposomes (Table 1) . Thus, liposome formulations containing 30 mol% of C12GEM showed a good entrapment efficiency and the introduction of HA-DPPE conjugates did not affect liposome drug incorporation.
Results from the carbazole assay showed that the amount of HA was similar (34 nmol HA/µmol lipid) in all the liposomal preparations (containing or not C12GEM), indicating that the presence of the drug did not affect the incorporation of HA.
Stability of liposomes was evaluated in the storage condition at 4 °C in HEPES buffer. Drug leakage was determined by removing aliquots of liposomes at various time intervals and reevaluating drug and phospholipid content after purification. Formulations were stable in the storage conditions for more than 21 days, maintaining 80% of their initial drug content. Moreover, the mean diameter of liposomes stored at 4 °C was evaluated and results showed that the liposomal preparations were stable for at least 21 days. Over this period no appreciable size change (<10% for all the preparations) and no precipitation or liposome aggregation were observed.
Differential Scanning Calorimetry (DSC)
DSC was performed to assess the possible interactions between DPPC and C12GEM and/or HA conjugated or not. The results are reported in Table 2 . The thermogram of pure DPPC presented the typical pre-transition corresponding to the conversion of the lamellar gel phase Lβ' into the ripple gel phase Pβ' and the main transition related to the passage from the Pβ' phase to the lamellar liquidcrystalline phase Lα (Supplementary information Fig. S1 ). The pretransition occurred at Tonset 37.2 °C and the main phase transition at Tonset 41.4 °C. Thermograms were similar for DPPC in the presence of unconjugated HA4800 and HA12000. However, the pre-transition was weaker for both molecular weights and the main transition was slightly shifted towards lower temperature with Tonset 40.3 °C for the higher molecular weight HA. These results demonstrate a weak interaction of HA with DPPC headgroups as already observed for a 1000 kDa HA [33] . When conjugated HA was added to hydrated DPPC, we could observe the disappearance of the pretransition in both samples.
The shape of the main transition was also changed becoming broader, a sign of insertion (Supplementary information Fig. S1 ). The Tonset was decreasing slightly for HA4800-DPPE (40.9 °C) and HA12000-DPPE (40.6 °C). These results suggest insertion of the conjugate within the DPPC membrane.
When C12GEM was added, the pretransition was abolished and the main transition was shifted to lower temperatures (Tonset 36.2 °C). This indicates a strong insertion of C12GEM within the DPPC membrane due to strong hydrophobic interactions as observed for other drugs [34] [35] [36] [37] [38] . This phenomenon persisted in the presence of conjugated HA of both molecular weights.
Liposomes morphology
The morphology of the different liposomal preparations was observed by TEM (Fig. 2) , which is the most used microscopic approach to obtain informations about liposome-drug interaction [39] .
The TEM assays indicated the coexistence of spherical unilamellar vesicles having a size between 150-190 nm in diameter that was consistent with the QELS data. In the case of empty liposomes (A, C, E), no increased electron density of internal region in comparison to background was observed, while liposomes containing C12GEM (B, D and F) revealed electron-dense areas consistent with the presence of the drug. It has already been shown that TEM is a useful technique for the characterization of modified-liposomes obtained conjugating a selective ligand to liposomes [40] . In our system, hyaluronated liposomes (C, D, E and F) revealed a particulate surface coating, which was absent in plain liposomes (A and B), and were decorated by fluffy dark structures (more visible in liposomes C and E, as indicated by the arrows), suggesting that molecules of HA were exposed on liposome surface.
Analysis of CD44 expression
The HA receptor CD44, an ubiquitous transmembrane cell surface molecule, is expressed at low levels on the surface of several normal cells and overexpressed in many cancer cells [22] . The receptor levels of a panel of pancreatic adenocarcinoma cell lines were evaluated by flow cytometry, labeling the cells with an anti-CD44 antibody, with the aim to identify the cell models to be used for further in vitro studies.
The results reported in Table 3 show that a certain number of cell lines had a high expression of CD44, the MiaPaCa2 cells displaying the highest expression (RMFI= 485 ± 32). On the contrary, the normal primary pancreatic mesenchymal VIT1 cells did not express detectable amount of CD44. 
CLSM study
Cellular uptake and localization of fluorescent plain (lipo) or hyaluronate (lipo HA4800 and lipo HA12000) liposomes were visualized by confocal microscopy using MiaPaCa2 (CD44 + ) and VIT1 (CD44 -) cells. To determine whether the liposome association to cells was due to an intracellular uptake or to a simple membrane adsorption, cell membranes were labeled with rhodamine-DHPE, while liposomes were labeled with fluorescein-5-(and-6)-sulfonic acid. This compound is more polar than carboxyfluorescein and, once inside liposomes, is relatively well retained.
Confocal analysis of the cell monolayers at 24 h (Fig. 4) showed that HA-liposome uptake by (Table 4 ). These results demonstrate that most of the HA-liposome binding to
MiaPaCa2 cells is attributable to the interaction with the cell surface CD44 receptor. These findings are similar to that observed in a previous study in which the intracellular distribution of HA-grafted liposomes was evaluated [41] .
In vitro cytotoxicity
Among the different GEM prodrugs previously prepared [18] , C12GEM was chosen to be The results reported in Table 5 show that C12GEM displayed a cytotoxicity at 72 h similar to that of GEM on both cell types.
The incorporation of C12GEM in liposomes increased its cytotoxic activity. In particular, lipo C12 HA4800 and lipo C12 HA12000 inhibited cell growth more than non-HA-liposomes (lipo C12). This result is in agreement with the higher cellular uptake of the HA-compared to non-HA-liposomes
shown by confocal microscopy analyses on MiaPaCa2 cells, that could enhance the entry of the drug into the cells and the protection against GEM inactivation.
Moreover, lipo C12 HA12000 displayed a stronger effect than lipo C12 HA4800 indicating an influence of the polymer MW in the targeting capacity. HA-liposomes loaded with doxorubicin [27, 42] and mitomycin C [26] have been already described and shown to significantly increase the toxicity of the respective drug against CD44 + cells. Surprisingly, VIT1 cells, which do not express CD44, showed a higher sensitivity towards HA-liposomes compared to non-HA-liposomes, although at a lower extent than MiaPaCa2 cells. This result is in contrast with the data obtained with confocal microscopy. However, since the in vitro cytotoxic assays were performed at 72 h, while the kinetics of cellular uptake was carried out only up to 24 h, we may speculate that in VIT1 cells a low expression of receptors other than CD44, such as RHAMM and ICAM-1 [43, 44] , able to bind HA, were responsible for the higher toxicity of HA-liposomes compared to non-HA-liposomes after long time of incubation. Indeed, unpublished results have shown that HA-liposomes and non-HAliposomes present a similar cytotoxic activity at 24 h on VIT1 cells.
Conclusions
Conjugates between HA of different MW (HA4800 and HA12000) and DPPE were prepared, characterized and introduced during the preparation of liposomes encapsulating C12GEM. The liposomes were characterized in terms of size, zeta potential and C12GEM encapsulation efficiency, DSC and TEM analysis.
The CLSM analysis and the in vitro cytotoxicity test showed higher affinity of HA12000 to CD44 receptor in comparison with HA4800.
Taken together these results demonstrate that HA-liposomes can function as tumor-targeted carrier for GEM prodrug.
Studies are in progress to deeply investigate the HA-liposome intracellular trafficking and to evaluate their in vivo antitumoral activity. 
